Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
Press Release Source: Bacterin International Holdings, Inc. On Monday June 27, 2011, 8:30 am EDT
BELGRADE, Mont., June 27, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, was added to the U.S. broad-market Russell 3000® Index after the market closed on June 24, 2011. The company was also added to the Russell Microcap® Index and Russell Global Index.
Annual reconstitution of Russell's U.S. indexes captures and ranks the 4,000 largest U.S. stocks as of the end of May by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index, as well as the appropriate growth and value style indexes. Membership in the Russell Microcap Index, which also remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
"Our addition to these Russell indexes represents another major milestone for Bacterin," said Guy Cook, the company's chairman and CEO. "It reflects that we're at a pivotal stage in our development in terms of our sales expansion and profitability. After double-digit sequential revenue gains over the last seven quarters, the greater visibility and awareness this listing is expected to bring couldn't come at a more favorable point in our development."
The Russell 3000 also serves as the U.S. component to the Russell Global Index. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $3.9 trillion in institutional assets currently are benchmarked to them. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.
About Russell
Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has about $161 billion in assets under management as of March 31, 2011, and serves individual, institutional and advisor clients in more than 35 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company. More information about Russell Indexes, including total returns, is available at http://www.russell.com/Indexes/data/default.asp.
Press Release Source: Bacterin International Holdings, Inc. On Monday June 27, 2011, 8:30 am EDT
BELGRADE, Mont., June 27, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, was added to the U.S. broad-market Russell 3000® Index after the market closed on June 24, 2011. The company was also added to the Russell Microcap® Index and Russell Global Index.
Annual reconstitution of Russell's U.S. indexes captures and ranks the 4,000 largest U.S. stocks as of the end of May by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index, as well as the appropriate growth and value style indexes. Membership in the Russell Microcap Index, which also remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
"Our addition to these Russell indexes represents another major milestone for Bacterin," said Guy Cook, the company's chairman and CEO. "It reflects that we're at a pivotal stage in our development in terms of our sales expansion and profitability. After double-digit sequential revenue gains over the last seven quarters, the greater visibility and awareness this listing is expected to bring couldn't come at a more favorable point in our development."
The Russell 3000 also serves as the U.S. component to the Russell Global Index. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $3.9 trillion in institutional assets currently are benchmarked to them. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.
About Russell
Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has about $161 billion in assets under management as of March 31, 2011, and serves individual, institutional and advisor clients in more than 35 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company. More information about Russell Indexes, including total returns, is available at http://www.russell.com/Indexes/data/default.asp.
Recent XTNT News
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/13/2026 11:33:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:05:34 AM
- Xtant Medical Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 • PR Newswire (US) • 05/07/2026 12:00:00 PM
- Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped • PR Newswire (US) • 05/06/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:20:24 PM
- Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product • PR Newswire (US) • 04/13/2026 01:04:00 PM
- Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial • PR Newswire (US) • 04/09/2026 12:00:00 PM
- Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat • IH Market News • 03/31/2026 02:54:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:16:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:05:23 AM
- Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/31/2026 11:00:00 AM
- Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 • PR Newswire (US) • 03/25/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 01:15:49 PM
- Xtant Medical Finalizes Companion Spine Transactions • PR Newswire (US) • 03/02/2026 01:00:00 PM
- Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference • PR Newswire (US) • 02/25/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 10:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 09:15:32 PM
- Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft • PR Newswire (US) • 12/11/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:52 PM
- Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine • PR Newswire (US) • 12/01/2025 09:05:00 PM

